drugset / Trial / NCT04347005
The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized, double-blind, placebo-controlled, single ascending dose study of AR882 in healthy adult males.
Timeline
- Start
- 2019-01-22
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AR882 | Unknown | — | — |
| Subject | Allopurinol | Small molecule | — | — |
| Subject | Febuxostat | Small molecule | — | — |
Indications
No indication recorded.